Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8999393 | ALMATICA | Sustained release formulations of lorazepam |
Jan, 2034
(10 years from now) |
Market Authorisation Date: 27 August, 2021
Treatment: Once daily treatment of anxiety disorder in adults
Dosage: CAPSULE, EXTENDED RELEASE;ORAL